Bio Essence (BIOE) Shares Outstanding (Diluted Average) (2021 - 2025)
Bio Essence (BIOE) recorded quarterly Shares Outstanding (Diluted Average) of $38.0 million in Q4 2025, little changed quarter-over-quarter from $38.0 million in Q4 2024, and little changed on a YoY basis from $38.0 million in Q4 2024.
Bio Essence (BIOE) Shares Outstanding (Diluted Average) (2021 - 2025) Analysis & Trends
Bio Essence's Shares Outstanding (Diluted Average) history runs 5 years deep, the most recent figure standing at $38.0 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Diluted Average) changed 0.0% year-over-year to $38.0 million; the TTM figure through Dec 2025 stood at $38.0 million (changed 0.0% YoY), while the FY2025 annual figure was $38.0 million, changed 0.0% from the prior year.
- Shares Outstanding (Diluted Average) was $38.0 million for Q4 2025 at Bio Essence, roughly flat from $38.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $38.0 million in Q1 2024 to a low of $33.0 million in Q2 2021.
- Historically, Shares Outstanding (Diluted Average) has averaged $34.8 million across 5 years, with a median of $33.0 million in 2021.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Diluted Average) changed 0.0% in 2022, then climbed 15.15% in 2024.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $33.0 million in 2021, then changed by 0.0% to $33.0 million in 2022, then gained by 8.92% to $36.0 million in 2023, then climbed by 5.72% to $38.0 million in 2024, then changed by 0.0% to $38.0 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $38.0 million (Q4 2025), $38.0 million (Q4 2024), and $38.0 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Bio Essence | - | - | 319,353.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 38.01 Mn |
| Dec 31, 2024 | 38.01 Mn |
| Jun 30, 2024 | 38.01 Mn |
| Mar 31, 2024 | 38.01 Mn |
| Dec 31, 2023 | 35.95 Mn |
| Sep 30, 2023 | 35.26 Mn |
| Jun 30, 2023 | 34.71 Mn |
| Mar 31, 2023 | 33.01 Mn |
| Dec 31, 2022 | 33.01 Mn |
| Sep 30, 2022 | 33.01 Mn |
| Jun 30, 2022 | 33.01 Mn |
| Mar 31, 2022 | 33.01 Mn |
| Dec 31, 2021 | 33.01 Mn |
| Sep 30, 2021 | 33.01 Mn |
| Jun 30, 2021 | 33.01 Mn |